Table of Contents

May 2016, Volume 23, Number 5

Profile

    • Nancy E Davidson

    Serendipity and purpose

    Endocr Relat Cancer 23 (5) P1-P3, doi:10.1530/ERC-16-0149 first published on 8 April 2016

Review

    • Lisa M Butler,
    • Margaret M Centenera,
    • and Johannes V Swinnen

    Androgen control of lipid metabolism in prostate cancer: novel insights and future applications

    Endocr Relat Cancer 23 (5) R219-R227, doi:10.1530/ERC-15-0556 first published on 29 April 2016

Research

    • Tanja Ignatov,
    • Holm Eggemann,
    • Elke Burger,
    • Serban Dan Costa,
    • and Atanas Ignatov

    Hormone receptor status does not alter the effect of trastuzumab in breast cancer

    Endocr Relat Cancer 23 (5) 349-355, doi:10.1530/ERC-16-0084 first published on 23 March 2016
    • Giampaolo Trivellin,
    • Ricardo R Correa,
    • Maria Batsis,
    • Fabio R Faucz,
    • Prashant Chittiboina,
    • Ivana Bjelobaba,
    • Darwin O Larco,
    • Martha Quezado,
    • Adrian F Daly,
    • Stanko S Stojilkovic,
    • T John Wu,
    • Albert Beckers,
    • Maya B Lodish,
    • and Constantine A Stratakis

    Screening for GPR101 defects in pediatric pituitary corticotropinomas

    Endocr Relat Cancer 23 (5) 357-365, doi:10.1530/ERC-16-0091 first published on 9 March 2016
    • Seo Ki Kim,
    • Jung-Woo Woo,
    • Jun Ho Lee,
    • Inhye Park,
    • Jun-Ho Choe,
    • Jung-Han Kim,
    • and Jee Soo Kim

    Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma

    Endocr Relat Cancer 23 (5) 367-376, doi:10.1530/ERC-15-0572 first published on 25 February 2016
    • Jaesung (Peter) Choi,
    • Yu Zheng,
    • David J Handelsman,
    • and Ulla Simanainen

    Glandular epithelial AR inactivation enhances PTEN deletion-induced uterine pathology

    Endocr Relat Cancer 23 (5) 377-390, doi:10.1530/ERC-16-0039 first published on 16 March 2016
    • Vinciane Corman,
    • Iulia Potorac,
    • Florence Manto,
    • Sarah Dassy,
    • Karin Segers,
    • Albert Thiry,
    • Vincent Bours,
    • Adrian F Daly,
    • and Albert Beckers

    Breast cancer in a male-to-female transsexual patient with a BRCA2 mutation

    Endocr Relat Cancer 23 (5) 391-397, doi:10.1530/ERC-16-0057 first published on 21 March 2016
    • Lena Lapkina-Gendler,
    • Itai Rotem,
    • Metsada Pasmanik-Chor,
    • David Gurwitz,
    • Rive Sarfstein,
    • Zvi Laron,
    • and Haim Werner

    Identification of signaling pathways associated with cancer protection in Laron syndrome

    Endocr Relat Cancer 23 (5) 399-410, doi:10.1530/ERC-16-0054 first published on 18 April 2016
    • J R Strosberg,
    • M Cives,
    • J Hwang,
    • T Weber,
    • M Nickerson,
    • C E Atreya,
    • A Venook,
    • R K Kelley,
    • T Valone,
    • B Morse,
    • D Coppola,
    • and E K Bergsland

    A phase II study of axitinib in advanced neuroendocrine tumors

    Endocr Relat Cancer 23 (5) 411-418, doi:10.1530/ERC-16-0008 first published on 14 April 2016
    • Graeme B Bolger,
    • Mariana F Bizzi,
    • Sergio V Pinheiro,
    • Giampaolo Trivellin,
    • Lisa Smoot,
    • Mary-Ann Accavitti,
    • Márta Korbonits,
    • and Antonio Ribeiro-Oliveira, Jr

    cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors

    Endocr Relat Cancer 23 (5) 419-431, doi:10.1530/ERC-15-0205
    • Anne-Lise Lecoq,
    • Say Viengchareun,
    • Mirella Hage,
    • Jérôme Bouligand,
    • Jacques Young,
    • Audrey Boutron,
    • Philippe Zizzari,
    • Marc Lombès,
    • Philippe Chanson,
    • and Peter Kamenický

    AIP mutations impair AhR signaling in pituitary adenoma patients fibroblasts and in GH3 cells

    Endocr Relat Cancer 23 (5) 433-443, doi:10.1530/ERC-16-0041 first published on 14 April 2016
    • Toru Tateno,
    • Tae Nakano-Tateno,
    • Shereen Ezzat,
    • and Sylvia L Asa

    NG2 targets tumorigenic Rb inactivation in Pit1-lineage pituitary cells

    Endocr Relat Cancer 23 (5) 445-456, doi:10.1530/ERC-16-0013 first published on 5 April 2016
    • Veronica Kalhori,
    • Melissa Magnusson,
    • Muhammad Yasir Asghar,
    • Ilari Pulli,
    • and Kid Törnquist

    FTY720 (Fingolimod) attenuates basal and sphingosine-1-phosphate-evoked thyroid cancer cell invasion

    Endocr Relat Cancer 23 (5) 457-468, doi:10.1530/ERC-16-0050 first published on 2 March 2016

Research Letter

    • Zhengping Zhuang,
    • Chunzhang Yang,
    • Ales Ryska,
    • Yuan Ji,
    • Yingyong Hou,
    • Sky D Graybill,
    • Petra Bullova,
    • Irina A Lubensky,
    • Günter Klöppel,
    • and Karel Pacak

    HIF2A gain-of-function mutations detected in duodenal gangliocytic paraganglioma

    Endocr Relat Cancer 23 (5) L13-L16, doi:10.1530/ERC-16-0148 first published on 29 April 2016
    • Bertrand Brieau,
    • Olivia Hentic,
    • Rachida Lebtahi,
    • Maxime Palazzo,
    • Makrem Ben Reguiga,
    • Vinciane Rebours,
    • Frederique Maire,
    • Pascal Hammel,
    • Philippe Ruszniewski,
    • and Pierre Fenaux

    High risk of myelodysplastic syndrome and acute myeloid leukemia after 177Lu-octreotate PRRT in NET patients heavily pretreated with alkylating chemotherapy

    Endocr Relat Cancer 23 (5) L17-L23, doi:10.1530/ERC-15-0543 first published on 1 March 2016
|

This Issue

May 2016; 23 (5)
Cover
  1. Profile
  2. Review
  3. Research
  4. Research Letter

Find articles in this issue containing these words:

New Articles: issue in progress

  1. December 2017, 24 (12)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most